Lilly antibody drug fails in a COVID-19 study; others go on on Monday, October 26, 2020 in The Hindu - Science with No comments The National Institute of Allergy and Infectious Diseases said a closer look did not verify a safety problem but found a low chance that the drug would prove helpful for hospitalised patients. from The Hindu - Science https://ift.tt/31LJHxy Share: Email ThisBlogThis!Share to XShare to Facebook
0 comments:
Post a Comment